Dr. Yvette Drew has a joint UBC faculty appointment at the rank of associate professor with OBGYN and the department of medicine, division of medical oncology. She previously worked as senior lecturer/medical oncologist at the Northern Centre for Cancer Care and the Clinical and Translational Research Institute, Newcastle University.
Prior to this, she undertook specialist medical oncology training at the Beatson West of Scotland Cancer Centre, Glasgow. During this time, she was awarded a prestigious Cancer Research UK-funded PhD fellowship investigating PARP inhibitors in ovarian cancer. She won a Merit award from the American Society of Clinical Oncology and was awarded the Medical Sciences Doctoral Prize (Newcastle university, 2013) for her PhD.
Yvette is a clinical trials investigator leading on trials from first-in-human phase 1 to phase 3. She is an active member of the BC Cancer GYN clinical trials group, the Canadian Clinical Trials group, OVCARE and GCI research community. Her goal is to develop novel therapies through early phase clinical trials in gynecological cancers. Research interests include non-cytotoxic targeted treatments and PARP inhibitor resistance.